These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27602059)

  • 1. Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores.
    Lagarde N; Delahaye S; Zagury JF; Montes M
    J Cheminform; 2016; 8(1):43. PubMed ID: 27602059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminating Agonist from Antagonist Ligands of the Nuclear Receptors Using Different Chemoinformatics Approaches.
    Lagarde N; Delahaye S; Jérémie A; Ben Nasr N; Guillemain H; Empereur-Mot C; Laville V; Labib T; Réau M; Langenfeld F; Zagury JF; Montes M
    Mol Inform; 2017 Oct; 36(10):. PubMed ID: 28671755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NRLiSt BDB, the manually curated nuclear receptors ligands and structures benchmarking database.
    Lagarde N; Ben Nasr N; Jérémie A; Guillemain H; Laville V; Labib T; Zagury JF; Montes M
    J Med Chem; 2014 Apr; 57(7):3117-25. PubMed ID: 24666037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Potential Endocrine Disrupting Chemicals Binding to Estrogen Receptor α (ERα) Using a Pipeline Combining Structure-Based and Ligand-Based in Silico Methods.
    Sellami A; Montes M; Lagarde N
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based pharmacophore modeling 1. Automated random pharmacophore model generation.
    Szwabowski GL; Cole JA; Baker DL; Parrill AL
    J Mol Graph Model; 2023 Jun; 121():108429. PubMed ID: 36804368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2D conformationally sampled pharmacophore: a ligand-based pharmacophore to differentiate delta opioid agonists from antagonists.
    Bernard D; Coop A; MacKerell AD
    J Am Chem Soc; 2003 Mar; 125(10):3101-7. PubMed ID: 12617677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification.
    Daga PR; Polgar WE; Zaveri NT
    J Chem Inf Model; 2014 Oct; 54(10):2732-43. PubMed ID: 25148595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probabilistic Approach for Virtual Screening Based on Multiple Pharmacophores.
    Madzhidov TI; Rakhimbekova A; Kutlushuna A; Polishchuk P
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31963467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two beta-adrenergic pharmacophores on the same molecule. A set of agonist-antagonist combinations.
    Kusiak JW; Heja G; Pitha J
    Biochem Pharmacol; 1987 Jan; 36(2):269-75. PubMed ID: 2880591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hot-spots-guided receptor-based pharmacophores (HS-Pharm): a knowledge-based approach to identify ligand-anchoring atoms in protein cavities and prioritize structure-based pharmacophores.
    Barillari C; Marcou G; Rognan D
    J Chem Inf Model; 2008 Jul; 48(7):1396-410. PubMed ID: 18570371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations.
    Polishchuk P; Kutlushina A; Bashirova D; Mokshyna O; Madzhidov T
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31757043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling.
    Meslamani J; Li J; Sutter J; Stevens A; Bertrand HO; Rognan D
    J Chem Inf Model; 2012 Apr; 52(4):943-55. PubMed ID: 22480372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pruned receptor surface models and pharmacophores for three-dimensional database searching.
    Sutherland JJ; O'Brien LA; Weaver DF
    J Med Chem; 2004 Jul; 47(15):3777-87. PubMed ID: 15239656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new crystal structure fragment-based pharmacophore method for G protein-coupled receptors.
    Fidom K; Isberg V; Hauser AS; Mordalski S; Lehto T; Bojarski AJ; Gloriam DE
    Methods; 2015 Jan; 71():104-12. PubMed ID: 25286328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring Dual Agonists for PPARα/γ Receptors using Pharmacophore Modeling, Docking Analysis and Molecule Dynamics Simulation.
    Ding TT; Liu YY; Zhang LM; Shi JR; Xu WR; Li SY; Cheng XC
    Comb Chem High Throughput Screen; 2022; 25(9):1450-1461. PubMed ID: 34182904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Histamine H
    Frandsen IO; Boesgaard MW; Fidom K; Hauser AS; Isberg V; Bräuner-Osborne H; Wellendorph P; Gloriam DE
    Sci Rep; 2017 Jul; 7(1):4829. PubMed ID: 28684785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid agonist and antagonist bivalent ligands as receptor probes.
    Portoghese PS; Ronsisvalle G; Larson DL; Yim CB; Sayre LM; Takemori AE
    Life Sci; 1982 Sep 20-27; 31(12-13):1283-6. PubMed ID: 6292615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining structure-based drug design and pharmacophores.
    Griffith R; Luu TT; Garner J; Keller PA
    J Mol Graph Model; 2005 Apr; 23(5):439-46. PubMed ID: 15781186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agents.
    Agrawal R; Jain P; Dikshit SN
    Comb Chem High Throughput Screen; 2012 Dec; 15(10):849-76. PubMed ID: 23140189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of new JNK3 inhibitory chemotypes via QSAR-Guided selection of docking-based pharmacophores and comparison with other structure-based pharmacophore modeling methods.
    Tuffaha GO; Hatmal MM; Taha MO
    J Mol Graph Model; 2019 Sep; 91():30-51. PubMed ID: 31158642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.